Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl+/- embryos

Sci Adv. 2022 Dec 2;8(48):eadd4136. doi: 10.1126/sciadv.add4136. Epub 2022 Nov 30.

Abstract

Cohesin rings interact with DNA and modulate the expression of thousands of genes. NIPBL loads cohesin onto chromosomes, and WAPL takes it off. Haploinsufficiency for NIPBL causes a developmental disorder, Cornelia de Lange syndrome (CdLS), that is modeled by Nipbl+/- mice. Mutations in WAPL have not been shown to cause disease or gene expression changes in mammals. Here, we show dysregulation of >1000 genes in WaplΔ/+ embryonic mouse brain. The patterns of dysregulation are highly similar in Wapl and Nipbl heterozygotes, suggesting that Wapl mutations may also cause human disease. Since WAPL and NIPBL have opposite effects on cohesin's association with DNA, we asked whether decreasing Wapl dosage could correct phenotypes seen in Nipbl+/- mice. Gene expression and embryonic growth are partially corrected, but perinatal lethality is not. Our data are consistent with the view that cohesin dynamics play a key role in regulating gene expression.

MeSH terms

  • Animals
  • Brain*
  • Cell Cycle Proteins / genetics
  • Female
  • Heterozygote
  • Humans
  • Mammals
  • Mice
  • Mutation
  • Phenotype
  • Pregnancy
  • Proteins
  • Transcriptome*

Substances

  • NIPBL protein, human
  • Cell Cycle Proteins
  • WAPL protein, mouse
  • Proteins